|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Designed biodegradable hydrogel structures prepared by stereolithography using poly(ethylene glycol)/poly(d,l-lactide)-based resins显示文摘 | T M Seck F P W Melchels J Feijen | 2010 | J Control Release2010，148，： | 1 |
| 2 | Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study 显示文摘 | Seck T Nauck M Sheng D | 2010 | Int J Clin Pract2010，64，5： | 1 |
| 3 | Cardiovascular (CV) safety of linagliptin in patients with type 2 diabetes (T2D):a pooled comprehensive analysis of prospectively adjudicated CV events in phase 3 studies显示文摘 | Johansen OE Neubacher D Seck T | 2013 | Diabetes2013，62，1： | 1 |
| 4 | Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on meffonnin nomothera- py: a randomized, double-blind, non-inferiority trial显示文摘 | ARECHAVALETA R SECK T CHEN Y | 2011 | Diabetes Obesity and metabolism2011，13，2： | 1 |
| 5 | Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study 显示文摘 | Seck T Nauek M Sheng D | 2010 | International journal of clinical practice2010，64，5： | 1 |
| 6 | Structure of in- fluenza virus haemagglutinin complexed with a neutralizing anti- body 显示文摘 | Bizebard T Gigant B Rigolet P Rasmussen B Diat O B? secke P Wharton S A Skehel J J Knossow M | 1995 | Nature1995，376，6535： | 1 |
| 7 | Efficacy and safety of treatment with sitagilptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy : a randomized, double- blind, non- inferiority trial显示文摘 | ARECHAVALETA R SECK T CHEN Y | 2011 | Diabetes Obes Metab2011，13，2： | 1 |
| 8 | Detailed analysis of five mutations in dihydropyrimidine dehydrogenase detected in cancer patients with 5 fluorouracil-related side effects显示文摘 | Gross E Ullrich T Seck K | 2003 | Hum Mutat2003，22，6： | 1 |
| 9 | Initial Therapy with the Fixed-Dose Combination (FDC) of Sitagliptin and Metformin (JANUMET?) in Patients with Type 2 Diabetes Mellitus (T2DM) Provided Superior Glycemic Control vs Metformin Alone, Based on the AACE/ACE Diabetes Algorithm显示文摘 | Seck T Engel S Golm G | 2011 | Diabetes2011，60，1： | 1 |
| 10 | Association of transforming growth factor-beta1 (TGFbeta1) T29-C gene polymorphism with bone mineral density (BMD),changes in BMD,and serum concentrations of TGF-beta1 in a population-based samle of postmenopausal german women显示文摘 | Hinke V Seck T Clanget C | 1998 | Journal of Bone and Mineral Research October1998，13，10： | 1 |
| 11 | Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs pioglitaznne in drug-naive patients with type 2 diabetes显示文摘 | Perez-Monteverde A Seck T Xu L | 2011 | Int J ClinPract2011，65，： | 1 |
| 12 | Serum parathyroid hormone,but not menopausal status,is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples显示文摘 | Seck T Diel I Bismar H | | 0，，02： | 1 |
| 13 | Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs pioglitazone in drug-naive patients with type 2 diabetes 显示文摘 | Perez-Monteverde A Seck T Xu L | | Int J Clin Pract0，65，9： | 1 |
| 14 | Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin : a 2 - year study 显示文摘 | Seck T Nauck M Sheng D | 2010 | Int J Clin Pract2010，64，： | 1 |
| 15 | Efficacy and safety of treat- ment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on mefformin monotherapy: a randomized, double-blind, non-inferiority trial 显示文摘 | Arechavaleta R Seck T Chen Y | 2011 | Diabetes Obes Metab2011，13，2： | 1 |
| 16 | Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy:a randomized,double-blind,non-inferiority trial显示文摘 | Arechavaleta R Seck T Chen Y | 2011 | Diabetes Obes Metab2011，13，2： | 1 |
| 17 | Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre-and postmenopausal women:relationship to age,menopause,bone turnover,bone volume,and circulating IGFs显示文摘 | Seck T Scheppach B Scharla S Diel I Blum WF Bismar H Schmid G Krempien B Ziegler R Pfeilschifter J | | 0，，： | 1 |
| 18 | Effcacy and safety of treatment with sitaliptin or glimepiride in patients wilh type 2 diabetes inadequately controlled on metformin monotherapy:arandomized,double-blind,non-inferiority trial显示文摘 | ARECHAVALELA R SECK T CHEN Y | 2011 | Diabetes Obes Metab2011，13，： | 1 |
| 19 | Safety and efficacy oftreatment with sitagliptin or glipizide in patients with type 2 dia-betes inadequately controlled on metformin : A 2-year study 显示文摘 | SECK T NAUCK M SHENG D | 2010 | Int J Clin Pract y2010，64，5： | 1 |
| 20 | Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy:a randomized,double-blind,non-inferiority trial显示文摘 | Arechavaleta R Seck T Chen Y | 2011 | Diabetes Obes Metab2011，13，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员